Latest News

Alzheimer's prevention trial to monitor reactions to higher disease risk status

A new clinical trial will soon begin testing whether early medical intervention in people at risk for Alzheimer's can slow down progression of disease pathology before symptoms emerge. As part of the overall prevention trial, neurodegenerative ethics experts will monitor how learning about their risk of developing Alzheimer's impacts trial participants.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • When pursuing goals, people give more weight to progress than setbacks

  • Herd mentality: Are we programmed to make bad decisions?

  • Growing shortage of stroke specialists seen in U.S.

  • Electronic cigarettes facilitate smoking cessation, new evidence shows

  • Severely mentally ill criminals: who goes to prison and who goes to psych institutions?

  • Bugs life: The nerve cells that make locusts ?gang up?

  • Firearm violence trends in the 21st century

  • Personality outsmarts intelligence at school: Conscientiousness and openness key to learning

  • Women are more empathetic toward their partner than men

  • Hugs help protect against stress, infection, say researchers

  •